The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation

NCT05769738 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease Exacerbation
COPD Exacerbation

Interventions

DRUG: Furosemide
DRUG: Normal saline

Sponsor

American University of Beirut Medical Center